期刊文献+

头颈癌术后调强放疗后口干症的综合评价 被引量:4

Combined assessment of xerostomia in head and neck cancer patients treated with surgery and postoperative intensity-modulated radiotherapy or conventional radiotherapy
下载PDF
导出
摘要 目的:对头颈癌术后调强和常规放疗后的口干症行前瞻性评估,以确定调强放疗预防口干症的效果。方法:82例头颈癌患者(口腔癌71例、口咽癌11例)分别行调强放疗(40例)和常规放疗(42例),在放疗前、后5个时间点,对口干进行综合评估。应用SPSS13.0软件包对数据进行统计学处理。结果:调强组腮腺平均放射剂量(22.21±5.02)Gy显著低于常规放疗组的(50.22±5.86)Gy(P<0.01);调强和常规组在放疗后6个月的中重度口干发生率,分别为RTOG评分法30%和92.9%,上海九院评分法25%和90.5%;口干问卷法15%和83.3%;调强组放疗后6个月时的静态和刺激唾液流为放疗前的51.0%和72.5%,常规组仅为放疗前的3.6%和8.2%(P<0.01);九院口干评分法结果与2种唾液流率均显著相关(r=0.79和0.78,P<0.01)。结论:调强放疗后口干症明显减少,推荐上海九院评分法用于口干症评估。 PURPOSE: This prospective longitudinal study was aimed to evaluate xerostomia in head and neck cancer patients treated with surgery followed by intensity-modulated radiotherapy (IMRT) or conventional radiotherapy (CRT). METHODS: 82 head and neck cancer patients who received surgery and postoperative radiotherapy were enrolled in this study. For radiation techniques, 40 patients were treated with IMRT and 42 patients were treated with CRT. The xerostomia was evaluated using combined methods at 5 time points before and after RT. SPSS13.0 software package was used for statistical analysis. RESULTS: The mean dose of the parotids in IMRT patients (22.21±5.02Gy) was significantly lower than that in CRT patients (50.22±5.86Gy) (P〈0.01). At 6-month after radiotherapy, the rates of moderate and severe xerostomia in patients with IMRT and CRT were 30% and 92.9% ,respectively, according to criteria of Radiation Therapy Oncology Group (RTOG); 25% and 90.5%, respectively, according to criteria of Shanghai Ninth People's Hospital; 15% and 83.3%, respectively, according to scores of xerostomia questionnaire (XQ) (all P〈0.01). The mean unstimulated and stimulated salivary flow rates in patients with IMRT at 6-month were 51.0% and 72.5%, respectively, compared with preradiation levels. Those in patients with CRT were 3.6% and 8.2%, respectively. The subjective score of criteria of Shanghai Ninth People's Hospital for xerostomia was in consistent the objective result from the saliva flow rate measurement (r=0.79 and 0.78, respectively, P〈0.01 ). CONCLUSIONS: Postoperative IMRT reduces significantly postradiation xerostomia in the study. The criteria of Shanghai Ninth People's Hospital is easy to use, and it should be recommended for evaluation of xerostomia.
出处 《中国口腔颌面外科杂志》 CAS 2009年第5期401-406,共6页 China Journal of Oral and Maxillofacial Surgery
基金 上海市科学技术委员会资助项目(08DZ2271100)~~
关键词 头颈癌 术后放疗 调强放疗 常规放疗 口干症 Head and neck cancer Postoperative radiotherapy Intensity-modulated radiotherapy (IMRT) Conventional radiotherapy (CRT) Xerostomia
  • 相关文献

参考文献16

  • 1Rades D, Fehlauer F, Wroblesky J, et al. Prognostic factors in head-and-neck cancer patients treated with surgery followed by intensity-modulated radiotherapy (IMRT), 3D-conformal radiotherapy , or conventional radiotherapy[J]. Oral Oncol, 2007, 43(6): 535-543.
  • 2Lee N, Puri DR, Blanco AI, et al. Intensity-modulated radiation therapy in head and neck cancers: an update [J]. Head Neck, 2007,29(4):387-400.
  • 3Marks JE, Davis CC, Gottsman VL, et al. The effect of radiation on parotid salivary function [J]. Int J Radiat Oncol Biol Phys, 1981,7(8):1013-1019.
  • 4Fu KK, Pajak TF, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) phase randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinoma: first report of RTOG 9003 [J].Int J Radial Oncol Biol Phys,2000,48( 1):7-16.
  • 5Bjordal K, Kaasa S, Mastekaasa A. Quality of life in patients treated for head and neck cancer: A follow up study 7 to 11 years after radiotherapy[J]. Int J Radiat Oncol Biol Phys, 1994,28(4): 847- 856.
  • 6Chao KS, Deasy JO, Markman J, et al. A prospective study of salivary function sparing in patients with head-and-neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results[J]. Int J Radiat Oncol Biol Phys,2001,49(4): 907-916.
  • 7Munter MW, Karger CP, Hoffner SG, et al. Evaluation of salivary gland function after treatment of head-and-neck tumors with intensity-modulated radiotherapy by quantitative pertech'netate scintigraphy[J]. Int J Radiat Oncol Biol Phys 2004,58(1):175-184.
  • 8王中和.口腔癌的放射治疗[J].中国口腔颌面外科杂志,2007,5(5):327-334. 被引量:16
  • 9王中和.头颈部恶性肿瘤的术后调强放射治疗[J].中华临床医学杂志,2008,9(9):36-39. 被引量:2
  • 10Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and European Organization for Research and Treatment of Cancer (EORTC)[J]. Int J Radiat Oncol Biol Phys, 1995,31 (5): 1341 - 1346.

二级参考文献40

  • 1王中和,RR米列奥,NJ卡西西.头颈部鳞癌术前放疗还是术后放疗——208例临床分析[J].中华放射肿瘤学杂志,1991,0(3):15-18. 被引量:3
  • 2屠规益,徐国镇.头颈晚期肿瘤的围手术期放射治疗[J].中华耳鼻咽喉头颈外科杂志,2005,40(11):801-804. 被引量:13
  • 3陈晓莉 张志愿 等.γ射线照射对钛板周围组织影响的实验研究[J].中华口腔医学杂志,1999,34:207-207.
  • 4[5]Chao KS,Deasy JO,Markman J,et al.A prospective study of salivary function sparing in patients with head and neck cancer receiving intensity modulated or three dimensional radiation therapy:initial result[J].Int J Radiat Oncol Biol Phys,2001,49:907-916.
  • 5[6]Lee N,Xia P,Akazawa P,et al.Intensity modulated radiotherapy in the treatment of nasopharyngeal carcinoma;An update of the UCSF experience[J].Int J Radiat Oncol Biol Phys,2002,53(1):12-22.
  • 6[7]Wendt CD,Peters LJ,Delclos L,et al.Primary radiotherapy in the treatment of stage Ⅰ and Ⅱ oral tongue cancers:Importance of the proportion of therapy delivered with interstitial therapy[J].Int J Radat Oncol Biol Phys,1990,(18):128-131.
  • 7[8]Lefebvre JL,Coche-Dequeant B,Buisset E,et al.Management of early oral cavity cancer[J].Eur J Cancer Oral Oncol,1994,30:216-220.
  • 8[9]Lapeyre M,Bollet MA,Racadot S,et al.Postoperative brachytherapy alone and combined postoperative radiotherapy and brachytherapy boost for squamous cell carcinoma of the oral cavity,with positive or close margins[J].Head Neck,2004,26:216-223.
  • 9[10]Jeremic B,Shibamoto Y,Stanisavljevic B,et al.Radiation therapy alone or with concurrent low-dose daily either cisplatin or carboplatin in local advanced unresectable squamous cell carcinoma of head and neck:a prospective randomized trial[J].Radiother Oncol,1997,43:29-37.
  • 10[11]Adelsten DJ,Adams GL,Wagner H,et al.An intergroup phase Ⅲ comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell carcinoma of head and neck cancer[J].J Clin Oncol,2003,21(1)92-98.

共引文献27

同被引文献52

  • 1江河,司勇锋,覃扬达,张政,黄波,陆锦龙,翁敬锦.恩度联合放化疗治疗鼻咽癌的临床疗效观察[J].环球中医药,2013,6(S2):111-112. 被引量:4
  • 2周永,唐安洲,谭颂华,李杰恩,蓝新海,方勤,陈平,毛荣清.鼻咽癌放疗后咽鼓管功能障碍的评估[J].中国耳鼻咽喉颅底外科杂志,2004,10(6):356-357. 被引量:9
  • 3司勇锋,韦海明,黄波,陆锦龙,李冰,兰桂萍,周日晶,张政.放射治疗后鼻窦炎黏膜组织形态学改变[J].中国耳鼻咽喉头颈外科,2005,12(11):729-732. 被引量:7
  • 4宗晓明,戚向敏,凌涤生.萎缩性舌炎病因探讨及治疗[J].口腔医学,2006,26(3):203-204. 被引量:12
  • 5姚中强,龙丽,栗占国.不同年龄发病的原发性干燥综合征的免疫学异常及临床特点的比较[J].中华风湿病学杂志,2006,10(11):683-686. 被引量:13
  • 6Fox PC,Busch KA,Baum BJ.Subjective reports of xerostomia and objective measures of salivary gland performance.J Am Dent Assoc,1987,115 (4):581-584.
  • 7Marks JE,Davis CC,Gottsman VL,et al.The effects of radiation of parotid salivary function.Int J Radiat Oncol Biol Phys,1981,7(8):1013-1019.
  • 8Bjordal K,Kaasa S,Mastekaasa A.Quality of life in patients treated for head and neck cancer:a follow-up study 7 to 11 years after radiotherapy.Int J Radiat Oncol Biol Phys,1994,28(4):847-856.
  • 9Fu KK,Pajak TF,Trotti A,et al.A Radiation Therapy Oncology Group (RTOG) phase Ⅲ randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas:first report of RTOG 9003.Int J Radiat Oncol Biol Phys,2000,48(1):7-16.
  • 10Cox JD,Stetz J,Pajak TF.Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC).Int J Radiat Oncol Biol Phys,1995,31 (5):1341-1346.

引证文献4

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部